Lido Advisors’s Mesa Laboratories MLAB Stock Holding History

Lido Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,201	Closed	-$665K	–	1027
2021 Q3	$665K	Buy	+2,201	New	+$626K	0.01%	494

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Lido Advisors's MLAB Position: Q4 2021 in Review

Lido Advisors sold out of Mesa Laboratories (MLAB) in Q4 2021, closing a stake of 2,201 shares — an estimated $665K sold.

Lido Advisors first reported a position in MLAB in Q3 2021 and held it in 1 quarter. The position peaked at $665K in Q3 2021. 178 funds tracked by Wall St. Rank hold MLAB as of Q4 2021.

Lido Advisors reported no remaining Mesa Laboratories position as of Q4 2021 after selling out during the quarter.
Lido Advisors sold 2,201 Mesa Laboratories shares in Q4 2021, an estimated $665K.
Lido Advisors first reported a position in Mesa Laboratories in Q3 2021 and held it in 1 quarter.
Lido Advisors's Mesa Laboratories position peaked at $665K in Q3 2021.
178 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2021.

Based on Lido Advisors's 13F filing for Q4 2021, filed 15 Feb 2022.